baber/WOPTO huggingface dataset:
Patent DK-425787-D0 (DK)
Inventor: STELLER WILLIAM STEVEN
IPC: A01N43/52
Filed: 1987-08-14
Abstract: Aqueous herbicidal compositions comprising on a weight basis 1.0% to 45% of a water soluble formula I imidazolinone acid salt <CHEM>    wherein A is CH; N or N->O;    W is oxygen or sulfur;    X is H, halogen, methyl or hydroxyl; Y and Z are each hydrogen, halogen, C1-C6 alkyl, hydroxyloweralkyl, C1-C6 alkoxy, C1-C4 alkylthio, phenoxy, C1-C4 haloalkyl, nitro, cyano, C1-C4 alkylamino, diloweralkylamino or C1-C4 alkylsulfonyl group; or phenyl optionally substituted with C1-C4 alkyl, C1-C4 alkoxy or halogen; difluoromethoxy, trifluoromethoxy, 1,1,2,3-tetrafluoroethoxy, C3-C8 straight or branched alkenyloxy optionally substituted with one to three halogens, or C3-C8 straight or branched alkynyloxy optionally substituted with one to three halogens; and, when taken together, Y and Z may form a ring which may optionally be substituted, in which YZ are represented by -(CH2)n-, -(CH)n-, where n is an integer of 3 or 4, and when A is N or N->O YZ may also be -(CH2)2-Q- or -(CH2)-Q-, wherein Q is oxygen or sulfur, with the proviso that X is hydrogen;    R1 is C1-C4 alkyl; R2 is C1-C4 alkyl or C3-C6 cycloalkyl; and when R1 and R2 are taken together with the carbon to which they are attached they may represent C3-C6 cycloalkyl optionally substituted with methyl; 0% to 20% urea; 0% to 30% nonionic surfactant and sufficient water to total 100% which has been buffered with a sufficient amount of acid to have an initial pH in a range of about 6 to pH 8.5.
Patent DK-447883-D0 (DK)
Inventor: LEWIS DAVID GERALD
IPC: F16D25/12
Filed: 1983-09-29
Abstract: A hydraulically engaged clutch comprises an actuating chamber wherein pressurized hydraulic fluid acts on a piston (40) to engage the clutch and a clutch chamber (26) for clutch cooling fluid which cools the stack of discs (32, 34). A spool valve (64) in a radial passage (60) in the clutch housing controls flow of cooling fluid to the clutch chamber (26) and is acted upon by the pressure in the actuating chamber to keep the valve open while clutch-engaging pressure is supplied from a pump (42). The spool (64) is also acted on by centrifugal force to close the valve when pressure in the actuating chamber falls sufficiently. The clutch chamber then drains through a passage (66) in order to avoid viscous drag. Preferably the valve (64) moves to the open position, as pressure rises in the actuating chamber before the piston (40) engages the clutch, in order to ensure cooling during engagement.
Patent DK-458486-D0 (DK)
Inventor: SCHOLZ MATTHEW T
IPC: A61L15/12
Filed: 1986-09-25
Abstract: A curable resin coated sheet useful as an orthopedic bandage which has reduced tack is provided. The resin coated sheet is pre-lubricated with a lubricant which is a) bonded to the resin, b) added to the resin or applied to the surface of the coated sheet, or c) a combination of a) and b). The lubricant is present in an amount to reduce the kinetic coefficient of friction of a surface of the coated sheet to less than 1.2.
Patent DK-472988-D0 (DK)
Inventor: BEACHEY EDWIN H
IPC: C12N1/21
Filed: 1988-08-24
Abstract: Non-virulent bacteria are disclosed into which have been cloned heterologous nucleotide sequences encoded for the expression of Streptococcal M protein antigens, which are effective to elicit opsonic antibodies against Streptococcal infections. These bacteria are useful for vaccination against Streptococcus pyogenes bacteria.
Patent DK-482286-D0 (DK)
Inventor: DEREZ FRANK GEORGE HENRY
IPC: C12R1/885
Filed: 1986-10-09
Abstract: A process for the treatment of an aqueous solution of carbohydrate origin which is difficult to filter and/or which produces a cloudy filtrate due to the presence of a phospholipid, in which the aqueous solution is treated before filtration with an enzyme composition containing a phospholipase, the ratio of phospholipase to total xylanase and beta-glucanase enzymes which may be present being at least 0.05 to 1, particularly at least 10 to 1. A novel enzyme composition which is suitable for use in the process contains a phospholipase in a concentration of at least 5000 units/gram total protein of the enzyme composition with a ratio of phospholipase to total xylanase and beta-glucanase which may be present of at least 0.05 to 1 particularly at least 10 to 1.
Patent DK-600284-D0 (DK)
Inventor: BYRON KEVIN CHRISTOPHER
IPC: G02F1/35
Filed: 1984-12-14
Abstract: An optical element is comprised of a length of polarisation-maintaining optical fibre and means for launching a pump signal into the fibre in order to induce birefringence therein. The amount of birefringence varies with the pump signal intensity. When a polarised signal is also launched into the fibre it is effected by the induced birefringence. In the extreme cases the element acts as a switch, permitting or preventing transmission of the polarised signal through the fibre. The fibre and signal wavelength may be such as to provide gain in a transmitted polarised signal. Two optical switches in series may comprise an optical AND gate.
Patent DK-648889-D0 (DK)
Inventor: ANDERSON MARTIN
IPC: C07C275/62
Filed: 1989-12-19
Abstract: This invention provides benzamide compounds of general formula <CHEM> wherein each of A and B independently represents a hydrogen or halogen atom, X represents an oxygen or a sulphur atom, n is 0, 1, 2, 3 or 4, each Z moiety independently represents a halogen atom or a C1-6 alkyl group, and Y represents a C1-6 haloalkyl group, a C1-6 haloalkoxy group, a group of formula <CHEM> wherein p is 0, 1 or 2, each Z min  moiety independently represents a halogen atom or a C1-6 alkyl group, Y min represents a C1-6 haloalkyl, C1-6 haloalkoxy, nitro or cyano group and Q represents N or C-H, or, when n is 2 or 3, Y may also be a halogen atom; processes for their preparation; and their use as pesticides.
Patent DK-660887-D0 (DK)
Inventor: GILLARD JOHN W
IPC: C07D417/12
Filed: 1987-12-16
Abstract: Compounds having the formula: <CHEM> are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labour, spontaneous abortion, dysmenorrhea, and migraine.
Patent HU-9301563-D0 (HU)
Title: Hemoglobin preparatives containing imido ester cross-bind and method for producing them
Inventor: GAZLICK ROBERT LEE
IPC: C07K1/14
Filed: 1991-10-03
Abstract: An imidoester, cross-linked hemoglobin composition useful in the transport of oxygen to living cells and being essentially free of any impurities, a P50 of at least 13 mm Hg and predominantly in tetramer form. Preferably, the cross-linked hemoglobin composition has a predominant molecular weight of at least 64,000. The purified and cross-linked hemoglobin has improved cross-link stability to autoxidation and can be used as a blood substitute for mammals or as an oxygen transport fluid.
Patent HU-896713-D0 (HU)
Title: Process for the preparation of medical instrument containing fisostigmine as agent being absorbed by skin
Inventor: HILLE THOMAS
IPC: A61L15/16
Filed: 1989-12-21
Abstract: The invention relates to a transdermal therapeutic system for administering physostigmine onto the skin, composed of a covering layer which is impermeable to the active ingredient, of an adhesive reservoir layer and, where appropriate, of a protective layer which can be detached again, a reservoir layer of which contains 10 - 90 % by weight of polymer material selected as from the groups consisting of block copolymers based on styrene and 1,3-dienes, polyisobutylenes, acrylate- and/or methacrylate-based polymers and esters of hydrogenated rosin, 0-30 % by weight of plasticisers based on hydrocarbons and/or esters and 0.1 - 20 % by weight of physostigmine.
Patent NO-881253-D0 (NO)
Inventor: SUGIHARA HIROSADA
IPC: A61K31/495
Filed: 1988-03-22
Abstract: Novel 1,4-disubstituted piperazine compounds represented by the formula (I): <CHEM>  wherein A is a condensed polycyclic hydrocarbon group;      R is a phenyl group substituted with a lower alkoxy group;      X is methylene group, carbonyl group or thiocarbonyl group;      and m is 2 or 3, and their salts are useful as a platelet activating factor antagonist.
Patent NO-884389-D0 (NO)
Inventor: HEILMANN PAUL
IPC: C21D1/613
Filed: 1988-10-04
Abstract: A process for heat treatment of metallic workpieces by heating in a vacuum furnace followed by quenching in a coolant gas under above-atmospheric pressure and with coolant-gas circulation.
Patent NO-893630-D0 (NO)
Inventor: GARTNER HERBERT ALFONS
IPC: C08F226/04
Filed: 1989-09-11
Abstract: Water-soluble, high molecular weight, linear copolymers of diallyl dimethyl ammonium chloride and acrylamide, are prepared by emulsion copolymerization of a major portion of the acrylamide monomer via stage-addition, and the addition of a chain transfer agent at the conclusion of said copolymerization to prevent branching and cross-linking.
Patent NO-913691-D0 (NO)
Inventor: GALIC MARY
IPC: C10N30/10
Filed: 1991-09-19
Abstract: The present invention deals with a particular antiemulsion agent which is useful in retarding foam and/or emulsion formation in an engine. In particular, the agent is effective at preventing or retarding emulsion or foaming in an engine oil.
Patent NO-914963-D0 (NO)
Inventor: DELMEE PETRUS HENRICUS MARIA
IPC: C25D1/08
Filed: 1991-12-16
Abstract: Described is a method for forming a sieve material (3) in which a sieve skeleton (2) is thickened in an electrolysis bath with metal; in the bath as used at least one chemical compound is present having properties of both a first and second class brightener in such concentration and added with such a rate in view of the Ah load that the internal stress in the finished sieve material (3) is reduced in comparison to a sieve material (3) produced in a bath comprising a conventional compound under conventional conditions. The invention also relates to a sieve material (3) formed with the method described. <IMAGE>
Patent NO-922396-D0 (NO)
Inventor: JENSEN TORBEN HOVE
IPC: C08J9/12
Filed: 1992-06-18
Abstract: PCT No. PCT/DK90/00347 Sec. 371 Date Jul. 20, 1992 Sec. 102(e) Date Jul. 20, 1992 PCT Filed Dec. 28, 1990 PCT Pub. No. WO91/09901 PCT Pub. Date Jul. 11, 1991.Method for the manufacture of a heat insulating foamed plastic material by foaming of a plastic material or plastic precursor material by means of a blowing agent where a mixture of krypton and xenon is at least partially used as a blowing agent. When using a mixture of krypton and xenon as the blowing agent, the ecological damages, particularly to the ozone layer, caused by the conventional CFC gases are avoided while a good heat insulating capacity is obtained at the same time.
Patent NO-922809-D0 (NO)
Inventor: MICHALSKI CATHERINE
IPC: A61P7/04
Filed: 1992-07-16
Abstract: Process for preparing a human thrombin concentrate from the PPSB fraction of plasma that does not involve any addition of factors of animal origin to induce activation of the prothrombin to produce thrombin, and which includes a viral inactivation step using solvent-detergent and purification by cation exchange chromatography. The choice of a protective medium ensures the high specific activity of the final product. The thrombin concentrate obtained using this process is intended for therapeutic use, either alone, to serve as a local hemostatic agent, or in combination with a fibrinogen concentrate to form biological glue.
Patent NO-923949-D0 (NO)
Inventor: HALLUNDBAEK JOERGEN
IPC: E21B4/02
Filed: 1992-10-09
Abstract: PCT No. PCT/DK91/00023 Sec. 371 Date Oct. 19, 1992 Sec. 102(e) Date Oct. 19, 1992 PCT Filed Jan. 25, 1991 PCT Pub. No. WO91/16520 PCT Pub. Date Oct. 31, 1991.A borehole (2) serves to produce e.g. hydrocarbons in a preferably soft or relatively soft underground formation (1), such as chalk or sandstone. The borehole (2) is surrounded by a substantially tubular reinforcement shell (9), which consists of formation material so compressed that the solid components of the material are substantially crushed to particles, and these are bonded together by the fluid or viscous components of the material and/or drilling mud. The borehole (2) if formed by first predrilling a small hole and then rolling said hole up to final borehole diameter by compressing the formation so that a reinforcement shell (9) of the desired thickness is formed. A self-propelling drive assembly (5) with a plurality of driven, elastic rollers (6) is used for this process, said rollers successively rolling down the borehole wall (7) and transferring the pressure force and moment from the drill bit (3) to the wall (7). Hereby horizontal boreholes can be formed far deeper into shallow hydrocarbon-bearing strata of the type which are found e.g. in the underground below the North Sea, so that these can be exploited profitably.
Patent NO-924254-D0 (NO)
Inventor: BRETESCHE BAUDOIN JAUSSEAUME D
IPC: F16L59/22
Filed: 1992-11-05
Abstract: The invention proposes a technique for insulating pipe bends by a defined cutting of cylindrical shells from an insulating material. The choice of the number of sections makes it possible to obtain optimum insulation. The packaging of the cut-out elements in their position before cutting allows economical and practical packaging. <IMAGE>
Patent NO-931291-D0 (NO)
Inventor: ROBSON DAVID JAMES
IPC: B01D15/04
Filed: 1993-04-02
Abstract: A material for absorbing hydrophobic water-immiscible liquids comprises lignocellulosic plant material which has been rendered relatively more absorbent to hydrophobic water-immiscible liquids by esterification of hydroxyl groups in the lignin of the lignocellulose material. The esterification in one aspect is by acetylation of the hydroxyl groups. Absorbing articles and methods for use with hydrophobic water-immiscible liquids are also disclosed.
Patent NO-941525-D0 (NO)
IPC: A61B17/58
Filed: 1994-04-26
Abstract: The invention relates to an anchoring organ (1) which is intended for implantation in tissues, essentially has a rotationally symmetrical design and is made of a tissue-compatible material, for supporting prostheses, artificial joint parts and the like. The anchoring organ has an external screw thread (2) which starts from its upper end (4) and extends in the direction of the opposite insertion end (3). The anchoring organ (1) is provided with at least one slot-shaped gap (5, 5a) located in the surface provided with the external screw thread at a distance from the insertion end (3). During introduction of the anchoring organ (1) and the healing-in time of the latter in a recess prepared in the tissue, the gap (5, 5a) is expediently provided with a detachable strip (6, 6a) which shields the gap (5, 5a). Once the anchoring organ (1) has settled in the tissue, the covering organ (6, 6a) can be exchanged for a holder (16), for a prosthesis and the like, which can be inserted in the gap. The invention also comprises an anchoring device which has at least one of said anchoring organs and said holders or connections. <IMAGE>
Patent NO-944332-D0 (NO)
Inventor: CHAN FERDINAND
IPC: A61P13/02
Filed: 1994-11-14
Abstract: PCT No. PCT/GB93/00890 Sec. 371 Date Jan. 18, 1995 Sec. 102(e) Date Jan. 18, 1995 PCT Filed Apr. 29, 1993 PCT Pub. No. WO93/23375 PCT Pub. Date Nov. 25, 1993Compounds having the general formula:    <IMAGE>  (3)  wherein each of R1 and R2 independently represents hydrogen or alkyl of 1 to 4 carbon atoms; A represents -O- or -CR4R5, where R4 and R5 are defined as for R1 or R2; R3 represents an adamantyl group; and Py represents a 3- or 4-pyridyl group, as free bases or their pharmaceutically acceptable salts are useful in treating androgen-dependent, especially prostatic, cancer.
Patent NO-951219-D0 (NO)
Inventor: HEEREMANS JOHANNA LOUISE MARIA
IPC: A61K47/48
Filed: 1995-03-30
Abstract: A pharmaceutical composition for the treatment of blood clots as well as a diagnostic composition for the detection of blood clots are described, which composition comprises a liposome or another biodegradable colloidal carrier, which has a plasminogen bonded to it as targeting device and has a plasminogen activator, in particular a tissue-type plasminogen activator (tPA), as clot-dissolving protein, or a diagnostic agent. A method is also described for the preparation of a composition having blood clot-decomposing properties, in which method: a) plasminogen is bound to liposomes, the affinity of the plasminogen for fibrin being essentially maintained; and b) a plasminogen activator is incorporated in the liposomes, under conditions such that the interaction of the plasminogen with the plasminogen activator is reduced. A method is also described for bonding plasminogen to liposomes, a substantially purified plasminogen being used as starting material.
Patent NO-953966-D0 (NO)
Inventor: PAUL MICHAEL
IPC: B26D7/18
Filed: 1995-10-05
Abstract: A blanking unit (10, 10a) for striking carton blanks from a sheet(s) of material comprises a top blanking frame (12) and a bottom blanking frame (14). The top blanking frame is vertically reciprocal relative to the bottom blanking frame so as to strike blanks from the sheet material when interposed between the frames. The bottom frame is formed with cutting edges (W1-W6; R1, R2) to shear through the sheet and the top frame is furnished with a number of profile plates (P1-P4) one for each blank (B1-B4) to be struck. Each profile plate conforms substantially to the general profile of the blank it is to strike and is adjustable in relation to that blank and relative to the remainder of the sheet.
Patent NO-960183-D0 (NO)
Inventor: ROERICHT HANS
IPC: A47C1/032
Filed: 1996-01-16
Abstract: An adjusting device for an office-chair or the like is proposed, which is constructed extremely simply and with few mechanical means and has an additional energy-storing device. For this, a hydraulic cylinder or bellows (27), which can be acted upon in either direction and whose fluid is guided in damped fashion on account of the back-part adjustment, is provided. <IMAGE>
Patent NO-963144-D0 (NO)
Inventor: ZHENGDI QIN
IPC: H04L5/02
Filed: 1996-07-26
Abstract: PCT No. PCT/FI95/00655 Sec. 371 Date Jul. 26, 1996 Sec. 102(e) Date Jul. 26, 1996 PCT Filed Nov. 28, 1995 PCT Pub. No. WO96/17446 PCT Pub. Date Jun. 6, 1996A receiver, and a data transmission method in a system wherein the CDMA multiple access method in a system wherein the CDMA multiple access method is utilized and wherein each data signal to be transmitted is multiplied by a pseudorandom code of a certain length, having a bit rate that is higher than that of the data signal to be transmitted. In order to ensure fast and inexpensive reception, the signal multiplied by the pseudorandom code is further modulated by a group of waveforms (f1 . . . fN) the number of which equals the number of bits in the pseudorandom code, the frequency domain given. The signal is converted in the receiver into a digital form and multiplied by the pseudorandom code which has been subjected to an inverse Fourier transform, and the multiplied signal is subjected to a Fourier transform.
Patent NO-964627-D0 (NO)
Inventor: WEINTRAUB PHILIP MARVIN
IPC: C07J41/00
Filed: 1996-11-01
Abstract: The invention discloses 3-ketosteroids of the following formula used to inhibit steroid C17-20 lyase: wherein R is OH, C1-C6 alkanoyl, C1-C6 alkanoyloxy, C1-C4 alkanol, COCH2OH, CO2H, CONR7R8, cyclopropyloxy, cyclopropylamino, acetylthioalkane, 2,2-dimethyldioxolan4-yl, 1,2-dihydroxyethyl and C1-4 alkylthiol; R1 is hydrogen, hydroxy or C1-6 alkyl; R and R1 together may indicate =O, that is an oxygen double bonded to the 17 carbon; R2, R3, and R4 are each independently hydrogen or C1-C6 alkyl; R5 and R6 are each independently hydrogen or OH; R5 and R6 together may indicate =O, that is an oxygen double bonded to the 11 carbon; R7 is hydrogen or C1-C8 alkyl; R8 is C1-C8 alkyl; and with the proviso that, when R is OH, then R1 is hydrogen; and with the proviso that, when R5 is OH, then R6 is hydrogen.
Patent NO-965094-D0 (NO)
Inventor: LAUFER STEFAN
IPC: A61K31/54
Filed: 1996-11-29
Abstract: PCT No. PCT/EP95/02078 Sec. 371 Date Mar. 28, 1997 Sec. 102(e) Date Mar. 28, 1997 PCT Filed May 31, 1995 PCT Pub. No. WO95/32971 PCT Pub. Date Dec. 7, 1995The present invention relates to heterocyclic compounds with the formula in which R1 to R7, B, a, and X have the meanings indicated in the specification. These compounds can be used for the treatment of diseases of the rheumatic variety and for the prevention of allergically-induced diseases.
Patent NO-985003-D0 (NO)
Inventor: INABA YUKIO
IPC: C07C41/09
Filed: 1998-10-27
Abstract: A mixed liquid of two or more components different in boiling temperature from each other and soluble in or compatible with each other is evaporated into a mixed vapor having a similar composition to that of the mixed liquid by using an apparatus having a thin film evaporator (1) having a feed inlet (1a) and a delivery outlet (1b), while forcedly circulating the non-evaporated portion of the mixed multi-component liquid by withdrawing the non-evaporated mixed liquid portion from the delivery side end portion of the evaporator and returning the mixed liquid portion into the feed side end portion of the evaporator through a circulating line (3), and the resultant mixed multi-component vapor can be used as a mixed material vapor for a gas phase catalytic reaction for producing, for example, a mono and/or a di-alkylether of an aromatic dihydroxy compound. <IMAGE>
Patent NO-992003-D0 (NO)
Inventor: JACOBSEN POUL
IPC: A61P5/30
Filed: 1999-04-27
Abstract: The present invention relates to therapeutically active compounds of formula (I), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
Patent NO-992935-D0 (NO)
Inventor: OHUCHIDA SHUICHI
IPC: C07C311/21
Filed: 1999-06-16
Abstract: The sulfonamide or carboamide derivatives of the formula (I) and a pharmaceutical composition which comprise them as an active ingredient: <CHEM> (wherein A ring, B ring is carbocyclic ring, heterocyclic ring; Z<1> is -COR<1>, -CH=CH-COR<1> etc.; Z<2> is H, alkyl etc.; Z<3> is single bond, alkylene; Z<4> is SO2, CO; Z<5> is alkyl, phenyl, heterocyclic ring etc.; R<2> is CONR<8>, O, S, NZ<6>, Z<7>-alkylene, alkylene etc.; R<3> is H, alkyl, halogen, CF3 etc.; R<4> is H, (substituted) alkyl etc.; n, t is 1-4). The compounds of the formula (I) can bind to receptors of PGE2 and show antagonistic activity against the action thereof or agonistic activity. Therefore, they are considered to be useful as medicine for inhibition of uterine contraction, analgesics, antidiarrheals, sleep inducers, medicine for increase of vesical capacity or medicine for uterine contraction, cathartic, suppression of gastric acid secretion, antihypertensive or diuretic agents.
Patent NO-994417-D0 (NO)
Inventor: HYLEN PER
IPC: B08B9/08
Filed: 1999-09-10
Abstract: The invention refers to a device and a method for the treatment of the inner surface of a container (2) having an opening. The device comprises a treatment member which is mountable in such a position that it extends into the container (2) through said opening and which is arranged to enable said treatment by the supply of a fluid. Furthermore, the device comprises a cover (1) arranged to close said opening and support the treatment member in said position and having a sealing surface abutting a sealing surface of the container. The cover (1) comprises a drainage passage for fluid consumed.